Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Reid Pitts

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Archives of Dermatology|July 21, 2004
Finasteride (Propecia) and the promotion of high-grade prostate cancerW Reid Pitts
The Journal of Urology|March 11, 2005
RE: Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancerW Reid Pitts
BJU International|May 18, 2007
Validation of the Pitts unified theory of prostate cancer, late-onset hypogonadism and carcinoma: the role of steroid 5alpha-reductase and steroid aromataseW Reid Pitts
The Journal of Urology|November 13, 2004
Re: inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationaleW Reid Pitts
The Journal of Urology|October 24, 2002
Re: Diethylstilbesterol revised: androgen deprivation, osteoporosis and prostate cancerW Reid Pitts
Clinical Prostate Cancer|March 26, 2004
The clinical rationale for immediate androgen deprivation without estrogen deprivationW Reid Pitts
The Journal of Urology|October 31, 2006
Re: bladder tumor markersW Reid Pitts
The Journal of Urology|October 9, 2003
The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancerDouglas S Scherr, W Reid Pitts
The Journal of Urology|January 17, 2002
Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancerDouglas Scherr, W Reid Pitts, E Darracott Vaughn
The Journal of Urology|May 7, 2002
Lymphoepithelioma-like carcinoma of the bladderJoseph N Ward, Wei F Dong, W Reid Pitts
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Archives of Dermatology|July 21, 2004
Finasteride (Propecia) and the promotion of high-grade prostate cancerW Reid Pitts
The Journal of Urology|March 11, 2005
RE: Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancerW Reid Pitts
BJU International|May 18, 2007
Validation of the Pitts unified theory of prostate cancer, late-onset hypogonadism and carcinoma: the role of steroid 5alpha-reductase and steroid aromataseW Reid Pitts
The Journal of Urology|November 13, 2004
Re: inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationaleW Reid Pitts
The Journal of Urology|October 24, 2002
Re: Diethylstilbesterol revised: androgen deprivation, osteoporosis and prostate cancerW Reid Pitts
Clinical Prostate Cancer|March 26, 2004
The clinical rationale for immediate androgen deprivation without estrogen deprivationW Reid Pitts
The Journal of Urology|October 31, 2006
Re: bladder tumor markersW Reid Pitts
The Journal of Urology|October 9, 2003
The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancerDouglas S Scherr, W Reid Pitts
The Journal of Urology|January 17, 2002
Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancerDouglas Scherr, W Reid Pitts, E Darracott Vaughn
The Journal of Urology|May 7, 2002
Lymphoepithelioma-like carcinoma of the bladderJoseph N Ward, Wei F Dong, W Reid Pitts
Pageof 3